Cargando…

Oxidative metabolism in cancer: A STAT affair?

STAT3 and STAT5 (STAT3/5) proteins are crucial mediators of cytokine- or growth factor-induced cell survival and proliferation. These transcription factors are frequently overactivated in a variety of solid tumors and hematopoietic neoplasms and are targets of various oncogenes with tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeais, Jérome, Gouilleux-Gruart, Valérie, Gouilleux, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876433/ https://www.ncbi.nlm.nih.gov/pubmed/24416651 http://dx.doi.org/10.4161/jkst.25764

Ejemplares similares

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
por: Bourgeais, Jerome, et al.
Publicado: (2016)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
por: Ramdani, Yanis, et al.
Publicado: (2022)

Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells
por: Bustany, Sophie, et al.
Publicado: (2016)

Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation
por: Meley, Daniel, et al.
Publicado: (2017)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
por: Lamendour, Lucille, et al.
Publicado: (2020)

Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine
por: Dakik, Hassan, et al.
Publicado: (2022)

“Ways in which the neonatal Fc-receptor is involved in autoimmunity”
por: Lamamy, Juliette, et al.
Publicado: (2021)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
por: Dumet, Christophe, et al.
Publicado: (2023)

The neonatal Fc receptor expression during macrophage differentiation is related to autophagy
por: Lamamy, Juliette, et al.
Publicado: (2022)

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin
por: Li, Geqiang, et al.
Publicado: (2010)

PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis
por: Berger, A, et al.
Publicado: (2014)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
por: Thibault, Gilles, et al.
Publicado: (2021)

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
por: Hallal, Rawan, et al.
Publicado: (2020)

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
por: Brachet-Botineau, Marie, et al.
Publicado: (2019)

FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
por: Bequignon, Emilie, et al.
Publicado: (2019)

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human
por: Etienne, Floriane, et al.
Publicado: (2020)

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis
por: Granel, Jérôme, et al.
Publicado: (2020)

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
por: Gatault, Philippe, et al.
Publicado: (2015)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice
por: Themanns, Madeleine, et al.
Publicado: (2016)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
por: Castaneda, Diana Cadena, et al.
Publicado: (2018)

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019)

A current affair: electrotherapy in wound healing
por: Hunckler, Jerome, et al.
Publicado: (2017)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
por: Gagez, A-L, et al.
Publicado: (2016)

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
por: Dalloneau, Emilie, et al.
Publicado: (2016)

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions
por: Neiveyans, Madeline, et al.
Publicado: (2019)

Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer
por: Chun, Kyung-Soo, et al.
Publicado: (2020)

VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
por: El Dor, Maya, et al.
Publicado: (2020)

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study
por: Gagez, Anne-Laure, et al.
Publicado: (2017)

Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
por: Kouzi, Farah, et al.
Publicado: (2019)

Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
por: Kouzi, Farah, et al.
Publicado: (2019)

Matricellular Proteins: A Sticky Affair with Cancers
por: Chong, Han Chung, et al.
Publicado: (2012)

Akt Isoforms: A Family Affair in Breast Cancer
por: Basu, Alakananda, et al.
Publicado: (2021)

The monkey gland affair
por: Borell, Merriley
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_r8khpu6pna3i0iluiamvrvuqv5